medicine semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug 1 receptor agonist GLP-1 Drug Semaglutide Substantially Reduced

Originally developed for type 2 diabetes management, several of these medications have received FDA approval for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities

Explore the EllieMD offerings, so you can make an informed decision that works best for you and your lifestyle

Use functional ingredients like botanicals and adaptogens to support health-forward reformulation

These can help bridge the hydration gap created by reduced overall food intake and can help you reach your daily fiber goal

How We Support You Beyond the Scale Monthly community seminars Mindset coaching & education Ongoing access to our team for questions and check-ins sustainable transformation supported by a care team that sees the whole you